# ImmunityBio, Inc. (IBRX) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $113M |
| 2024 | $15M |
| 2023 | $622,000 |
| 2022 | $240,000 |
| 2021 | $934,000 |
| 2020 | $605,000 |
| 2019 | $2M |
| 2018 | $47,000 |
| 2017 | $45,000 |
| 2016 | $44,000 |
| 2015 | $236,000 |
| 2014 | $641,000 |
| 2013 | $600,000 |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $44M |
| 2025-09-30 | $32M |
| 2025-06-30 | $26M |
| 2025-03-31 | $17M |
| 2024-09-30 | $6M |
| 2024-06-30 | $1M |
| 2024-03-31 | $40,000 |
| 2023-09-30 | $82,000 |
| 2023-06-30 | $41,000 |
| 2023-03-31 | $360,000 |
| 2022-09-30 | $118,000 |
| 2022-06-30 | $35,000 |
| 2022-03-31 | $14,000 |
| 2021-09-30 | $66,000 |
| 2021-06-30 | $339,000 |
| 2021-03-31 | $139,000 |
| 2020-09-30 | $151,000 |
| 2020-06-30 | $436,000 |
| 2020-03-31 | $165,000 |
| 2019-09-30 | $12,000 |
| 2019-06-30 | $17,000 |
| 2019-03-31 | $5,000 |
| 2018-09-30 | $31,000 |
| 2018-06-30 | $4,000 |

Source: [MarketCapTrends](https://marketcaptrends.com/company/IBRX/revenue)